USE OF MONOCLONAL ANTIBODY PANEL TO IDENTIFY MALIGNANT CELLS IN CEREBROSPINAL FLUID
- 1 May 1984
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 323 (8386), 1095-1098
- https://doi.org/10.1016/s0140-6736(84)92508-x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissuesInternational Journal of Cancer, 1983
- Monoclonal antibody UJ 127:11 detects a 220,000‐240,000 kdal. Glycoprotein present on a sub‐set of neuroectodermally derived cellsInternational Journal of Cancer, 1983
- USE OF TWO EPITHELIUM-SPECIFIC MONOCLONAL ANTIBODIES FOR DIAGNOSIS OF MALIGNANCY IN SEROUS EFFUSIONSThe Lancet, 1982
- A NEW MARKER FOR HUMAN CANCER CELLS. 3. IMMUNOCYTOCHEMICAL DETECTION OF MALIGNANT CELLS IN SEROUS FLUIDS WITH THE Cal ANTIBODYThe Lancet, 1982
- Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinantsNature, 1982
- Monoclonal antibodies provide specific intramolecular markers for the study of epithelial tonofilament organization.The Journal of cell biology, 1982
- Distinctive functional characteristics of human „T”︁ lymphocytes defined by E rosetting or a monoclonal anti‐T cell antibodyEuropean Journal of Immunology, 1981
- Tissue cultures from cerebrospinal fluid specimens in the study of human brain tumorsJournal of Neurosurgery, 1978
- Infiltration of the Leptomeninges by Systemic CancerArchives of Neurology, 1974
- A Membrane Filter Technic for Cytology of Spinal FluidAmerican Journal of Clinical Pathology, 1962